Hanmi Science Co Equity 2024

Hanmi Science Co Aktienanalyse

What does Hanmi Science Co do?

Hanmi Science Co Ltd is a South Korean company specializing in the manufacturing of pharmaceutical products, biologics, and medical devices. The company was founded in 1973 as a chemical company and obtained the license for drug manufacturing in 1990, expanding its product range to include pharmaceuticals. Today, the company's business model includes three main areas: research and development, manufacturing and sales of drugs, and sales of medical devices. Hanmi aims to develop and produce innovative and high-quality products to improve people's health worldwide. In the field of research and development, Hanmi Science is a leading company. It specializes in the research and development of novel drugs and biologics. The company has an impressive track record in the development and marketing of innovative drugs for the treatment of diabetes, cancer, and rare diseases. This includes a range of biosimilars produced using biotechnological methods that are more affordable compared to original medical substances. Hanmi also has a state-of-the-art production infrastructure that meets the highest quality standards and ensures reliable supply. In the field of drug manufacturing, the company produces generics and biosimilars that are sold in more than 50 countries worldwide. Hanmi also specializes in the production of chemotherapeutics and parenteral drugs that have proven efficacy and safety. The medical device sales division focuses on marketing high-quality medical devices, including diagnostic and monitoring devices used in the medical field. Hanmi also distributes a range of medical consumables, including transfusion sets, syringes, infusion sets, and catheters. Hanmi Science Co Ltd offers a wide range of products that can be categorized into various categories. Among the pharmaceutical products are antidiabetic drugs, anticancer agents, antidepressants, antibiotics, antiviral medications, and products for the treatment of rare diseases. The portfolio also includes biosimilars of botulinum toxin, insulin, and humiderm among the biologics. Overall, Hanmi Science Co Ltd holds a strong position in the South Korean market and has also established a good reputation internationally. With its focus on research and development and the production of high-quality drugs and medical devices, the company has a promising future. Hanmi Science Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Hanmi Science Co's Equity

Hanmi Science Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Hanmi Science Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Hanmi Science Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Hanmi Science Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Hanmi Science Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Hanmi Science Co stock

What is the equity of Hanmi Science Co this year?

Hanmi Science Co has equity of 787.51 B KRW this year.

What was the equity of Hanmi Science Co compared to the previous year?

The equity of Hanmi Science Co has increased/decreased by 8.66% increased compared to the previous year.

What impact does a high equity have on investors of Hanmi Science Co?

A high equity is advantageous for investors of Hanmi Science Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Hanmi Science Co?

A low equity can be a risk for investors of Hanmi Science Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Hanmi Science Co affect the company?

An increase in equity of Hanmi Science Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Hanmi Science Co affect the company?

A reduction in equity of Hanmi Science Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Hanmi Science Co?

Some factors that can affect the equity of Hanmi Science Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Hanmi Science Co so important for investors?

The equity of Hanmi Science Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Hanmi Science Co take to change the equity?

To change equity, Hanmi Science Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Hanmi Science Co pay?

Over the past 12 months, Hanmi Science Co paid a dividend of 200 KRW . This corresponds to a dividend yield of about 0.59 %. For the coming 12 months, Hanmi Science Co is expected to pay a dividend of 200 KRW.

What is the dividend yield of Hanmi Science Co?

The current dividend yield of Hanmi Science Co is 0.59 %.

When does Hanmi Science Co pay dividends?

Hanmi Science Co pays a quarterly dividend. This is distributed in the months of January, January, January, July.

How secure is the dividend of Hanmi Science Co?

Hanmi Science Co paid dividends every year for the past 7 years.

What is the dividend of Hanmi Science Co?

For the upcoming 12 months, dividends amounting to 200 KRW are expected. This corresponds to a dividend yield of 0.59 %.

In which sector is Hanmi Science Co located?

Hanmi Science Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hanmi Science Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hanmi Science Co from 8/14/2024 amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Hanmi Science Co pay the last dividend?

The last dividend was paid out on 8/14/2024.

What was the dividend of Hanmi Science Co in the year 2023?

In the year 2023, Hanmi Science Co distributed 196.078 KRW as dividends.

In which currency does Hanmi Science Co pay out the dividend?

The dividends of Hanmi Science Co are distributed in KRW.